Qiagen's QuantiFERON-TB Test Now in China - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 6:43PM CDT
Qiagen plans to launch QuantiFERON-TB Gold In-Tube in China.
Why Symantec Corporation, Biogen Idec, and Alexion Pharmaceuticals Are Today’s 3 Worst Stocks
John Divine, The Motley Fool - Motley Fool - Fri Mar 21, 6:39PM CDT
The S&P 500 Index hit all-time highs today. Then it steadily declined for the remainder of the day, driven by a slumping health-care sector. With Symantec Corporation being the lone exception, two of the three biggest losers in the stock...
Glaxo's MAGE-A3 Candidate Disappoints Again - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 6:36PM CDT
Glaxo announced disappointing data from the phase III MAGRIT study on its MAGE-A3 cancer immunotherapeutic.
Good News for Johnson & Johnson - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 6:30PM CDT
Johnson & Johnson halted an early phase III study on a three-month formulation of Invega Sustenna.
Biotechs, Medicals Get Hurt Amid Price-Inquiry News
at Investor's Business Daily - Fri Mar 21, 5:26PM CDT
Two normally healthy biotech stocks suffered critical declines Friday, while most other medical names on the IBD 50 remained in fairly stable condition. Still, the biotech illness spread to other drug stocks. As a result, six of the seven biggest...
AVEO Regains AV-203 Rights from Biogen - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 5:10PM CDT
AVEO Oncology (AVEO) recently announced that it has regained worldwide rights of candidate AV-203 from Biogen Idec (BIIB).
Biotechs, Software, Generics Pace U.S. Stocks Lower
at Investor's Business Daily - Fri Mar 21, 4:04PM CDT
Stocks lost initial gains as a summary sell-off of biotech and ethical drug names punched the Nasdaq composite sharply lower. All but two of the top 10 stocks within the IBD 50 also fell. The Nasdaq composite fell nearly 1%. That shaved the index's...
U.S. Stocks Lose Gains, Biotechs Get Hammered
at Investor's Business Daily - Fri Mar 21, 3:26PM CDT
Stocks lost initial gains as a summary sell-off of biotech and ethical drug names punched the Nasdaq composite sharply lower Friday. The Nasdaq composite fell nearly 1%. That shaved the index's weekly advance to less than 0.8%. The S&P 500's 0.6%...
Favorable Data for Myriad Genetics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 2:30PM CDT
Shares of Myriad Genetics gained 1.78% at yesterday's close.
Gilead Pricing Probed By House; Biotech Stocks Drop
at Investor's Business Daily - Fri Mar 21, 11:29AM CDT
Biotech stocks were selling off hard Friday, and consensus on Wall Street seemed to pin the blame on a letter sent by several House Democrats to Gilead Sciences (GILD) asking for a briefing on the price of its hepatitis C blockbuster Sovaldi. The...
Nasdaq Back Above Water; Green Plains Jumps
at Investor's Business Daily - Fri Mar 21, 10:54AM CDT
Stocks were higher in unison once again near Friday's halftime after trading mixed earlier. The Dow Jones industrial average rose 0.7%, while the S&P 500 climbed 0.6%. After falling as much as 0.6% earlier, the Nasdaq has turned fractionally higher....
Trial Protocol Submission Lifts Heat Biologics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 10:30AM CDT
Shares of Heat Biologics gained more than 8% to close the trading session on March 20 at $7.42 .
Dow, S&P 500 Up, Nasdaq Slips; Drugmakers Falling Hard
at Investor's Business Daily - Fri Mar 21, 9:31AM CDT
Stocks got off to a positive start Friday, but slipped into mixed trade as several drugmakers fell abruptly and pulled the Nasdaq into negative territory. The Dow Jones industrial average was ahead 0.4%, the S&P 500 up 0.3%. The Nasdaq fell 0.3%,...
Alexion Pharmaceuticals (ALXN) Is Today's Water-Logged And Getting Wetter Stock
at The Street - Fri Mar 21, 9:26AM CDT
Trade-Ideas LLC identified Alexion Pharmaceuticals (ALXN) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
Sinovac Biotech (SVA) Soars: Stock Rises 17.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 8:39AM CDT
Sinovac Biotech Ltd. was a big mover last session, as its shares rose over 17% on the day.
Strength Seen in ZIOPHARM Oncology (ZIOP): Stock Up 11.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 8:04AM CDT
ZIOPHARM Oncology, Inc. was a big mover last session, as the company saw its shares rise nearly 12% on the day.
Oncolytics Biotech (ONCY) Jumps: Stock Rises 5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 7:57AM CDT
Oncolytics Biotech Inc. (ONCY) was a big mover last session, as the company saw its shares rise over 5% on the day.
Synta Pharmaceuticals Corp. (SNTA) Catches Eye: Stock Jumps 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 7:44AM CDT
Synta Pharmaceuticals Corp. was a big mover last session, as the company saw its shares rise 9.5% on the day.
Genomic Health Unveils Oncotype DX Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 5:15PM CDT
Genomic Health presents results from multiple Oncotype DX breast cancer studies at the 9th European Breast Cancer Conference.
Horizon Pharma to Buy Vidara, Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 3:09PM CDT
Horizon Pharma announced that it will acquire Vidara Therapeutics International Ltd.